---
categories: 
- Database
- Release
date: 2024-04-11
title: Database release
github_url: https://github.com/vanallenlab/moalmanac-db/releases/tag/v.2024-04-11
---
Added entries:
- (FDA) ABL1 p.T315I and sensitivity to ponatinib for patients with acute lymphoid leukemia.
- (FDA) ABL1 p.T315I and sensitivity to ponatinib for patients with chronic myeloid leukemia.
- (FDA) BCR::ABL1 and sensitivity to ponatinib in combination with chemotherapy for patients with acute lymphoid leukemia.
- (FDA) BCR::ABL1 and sensitivity to ponatinib for patients with acute lymphoid leukemia.

Revised entries:
- The therapeutic strategy for two records with `ROS inhibition` were changed to `ROS1 inhibition`
- _MRE11A_ somatic variants and sensitivity to enzalutamide in combination with talazoparib for patients with prostate cancer was updated to have the gene symbol be `MRE11`

All records were also updated to have a `_deprecated` field, which is a boolean value to hide the record from appearing on https://moalmanac.org. 